Results of medical treatment and metabolic risk factors in children with urolithiasis


Data on conservative treatment in children with urolithiasis are limited. The aim of the study was to determine the metabolic etiology and results of conservative treatment in children with urolithiasis. We evaluated the clinical presentation and metabolic features of 112 children with urolithiasis. The mean age at diagnosis of urolithiasis was 3.9 (range 0.1–18) years, and follow-up duration was 16.7 (range 1–36) months. The most common presenting symptoms were flank or abdominal pain and restlessness (25%). Urine analysis revealed metabolic abnormalities in 92% of cases, including hypocitraturia (42%), hyperoxaluria (32.1%), hypercalcuria (25%), hyperuricosuria (9.8%), and cystinuria (2.7%). Patients who had metabolic risk factors were treated according to underlying metabolic abnormalities. About half of these patients were stone free or stones were diminished in size. These results showed that early recognition and treatment of urinary metabolic abnormalities will reduce the number of invasive procedures and renal damage in children with urolithiasis.

This is a preview of subscription content, access via your institution.


  1. 1.

    Goldfarb DS (2003) Increasing prevalence of kidney stones in the United States. Kidney Int 63:1951–1952

    Article  Google Scholar 

  2. 2.

    VanDervoot K, Wiesen J, Frank R, Vento S, Crosby V, Chadra M, Trachtman H (2007) Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 177:2300–2305

    Article  Google Scholar 

  3. 3.

    Remzi D, Çakmak F, Erkan I (1980) A study on urolithiasis incidence in school age children. J Urol 123:608–610

    CAS  Article  Google Scholar 

  4. 4.

    Sirin A, Emre S, Alpay H, Nayir A, Bilge I, Tanman F (1995) Etiology of chronic renal failure in Turkish children. Pediatr Nephrol 9:549–552

    CAS  Article  Google Scholar 

  5. 5.

    Turkey National Hemodialysis (2004) Transplantation and Nephrology Registry Report of Turkey 2003. Istanbul. Available at:

  6. 6.

    Erbagci A, Erbagci AB, Yılmaz M, Yagci F, Trakcioglu M, Yurtseven C, Koyluoglu O, Sarica K (2003) Pedaitric urolithiasis evaluation of risk factors in 95 children. Scand J Urol Nephrol 37:129–133

    CAS  Article  Google Scholar 

  7. 7.

    Bak M, Ural R, Agin H, Serdaroglu E, Calkavur S (2009) The metabolic etiology of urolithiasis in Turkish children. Int Urol Nephrol 41:453–460

    CAS  Article  Google Scholar 

  8. 8.

    Cameron MA, Sakhaee K, Moe OW (2005) Nephrolithiasis in children. Pediatr Nephrol 20:1587–1592

    Article  Google Scholar 

  9. 9.

    Polito C, Cioce F, La Manna A, Maiello R, Di Torro R (1999) Renal calyceal microlithiasis: clinical presentation may precede sonographic evidence. Clin Pediatr (Phila) 38:521–524

    CAS  Article  Google Scholar 

  10. 10.

    Alon US (2009) Medical treatment of pediatric urolithiasis. Pediatr Nephrol 24:2129–2135

    Article  Google Scholar 

  11. 11.

    Alpay H, Ozen A, Gokce I, Biyikli N (2009) Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 24:2203–2209

    Article  Google Scholar 

  12. 12.

    Ozkutan BH, Küçükaydın M, Gündüz Z, Kabaklioğlu M, Okur H, Turan C (2000) Urolithiasis in childhood. Pediatr Surg Int 16:60–63

    Article  Google Scholar 

  13. 13.

    Oner A, Demircin G, İpekcioğlu H, Bulbul M, Ecin N (1997) Etiological and clinical patterns of urolithiasis in Turkish children. Eur Urol 31:453–458

    CAS  Article  Google Scholar 

  14. 14.

    Perrone HC, Santos DR, Santos MV, Pinherio ME, Toporovski J, Ramos OL, Schor N (1992) Urolithiasis in childhood: metabolic evaluation. Pediatr Nephrol 6:54–56

    CAS  Article  Google Scholar 

  15. 15.

    Gerhart JP, Herzberg GZ, Jeffs RD (1991) Chilhood urolithiasis: experience and advances. Paediatrics 87:445–450

    Google Scholar 

  16. 16.

    Hari P, Bagga A, Vasudev V, Singh M, Srivastava RN (1995) Aetiology of nephrolithiasis in north Indian children. Pediatr Nephrol 9:474–475

    CAS  Article  Google Scholar 

  17. 17.

    Dursun I, Poyrazoglu MH, Düşünsel R, Gündüz Z, Gürgöze MK, Demirci D, Küçükaydın M (2008) Pediatric urolithiasis: an 8-year experience of single center. Int Urol Nephrol 40:3–9

    Article  Google Scholar 

  18. 18.

    Hulton SA (2001) Evaluation of urinary tract calculi in children. Arch Dis Child 84:320–323

    CAS  Article  Google Scholar 

  19. 19.

    Tefekli A, Esen T, Ziylan O, Erol B, Armağan A, Ander H, Akıncı M (2000) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 459:1–10

    Google Scholar 

  20. 20.

    Kalorin CM, Zabinski A, Okpareke I, White M, Kogan BA (2009) Pediatric urinary stones disease-does age matter? J Urol 181:2267–2271

    Article  Google Scholar 

  21. 21.

    Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR (2009) Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 42:471–475

    Article  Google Scholar 

  22. 22.

    Tekin A, Tekgül S, Atsu N, Bakkaloglu M, Kendi S (2002) Oral potassium citrate treatment for idiopathic hypocitraturia in children with calcium urolithiasis. J Urol 168:2572–2574

    CAS  Article  Google Scholar 

  23. 23.

    Sarica K (2006) Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 34:96–101

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Metin Kaya Gürgöze.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gürgöze, M.K., Sarı, M.Y. Results of medical treatment and metabolic risk factors in children with urolithiasis. Pediatr Nephrol 26, 933–937 (2011).

Download citation


  • Urolithiasis
  • Hypocitraturia
  • Hyperoxaluria
  • Hypercalcuria
  • Hyperuricosuria
  • Cystinuria
  • Conservative treatment